Metraipolis › archive › dc_499893df7e56

Patent Term Extension for Innovative Drugs in China: A Cohort Study from 2021 to 2024 — Europe PMC PMID:41379403

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41379403
DOI
10.1007/s43441-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-07T17:23:20.539Z
SHA-256 of the archived text
23bcb531112223f9fe84ed4b783d1b8ccf0236cf4f8d6a962eb542a5292a1ac2
Stable URL of this page
https://metraipolis.com/documento/dc_499893df7e56

How to cite

Patent Term Extension for Innovative Drugs in China: A Cohort Study from 2021 to 2024 — Europe PMC PMID:41379403 — Europe PMC (en), https://europepmc.org/article/MED/41379403 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_499893df7e56 (Metraipolis archive dc_499893df7e56, sha256 23bcb531112223f9fe84ed4b783d1b8ccf0236cf4f8d6a962eb542a5292a1ac2)
BibTeX
@misc{dc499893df7e56,
  title = {Patent Term Extension for Innovative Drugs in China: A Cohort Study from 2021 to 2024 — Europe PMC PMID:41379403},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41379403},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_499893df7e56; sha256 23bcb531112223f9fe84ed4b783d1b8ccf0236cf4f8d6a962eb542a5292a1ac2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41379403. Agents can read the archived copy with the MCP tool read_document.